View in EDS

Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.

Saved in:
Bibliographic Details
Title: Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.
Authors: Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org., Zhang HH; BioMed Valley Discoveries Inc., Kansas City, Missouri., Pezeshki A; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Goel S; Montefiore/Albert Einstein Cancer Center, Bronx, New York., Murthy R; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang-Gillam A; Washington University in St. Louis, St. Louis, Missouri., Shepard DR; Cleveland Clinic, Cleveland, Ohio., Helgason T; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Masters T; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Klang M; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Huang SY; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sakamuri D; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Raina A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Torrisi J; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Solomon SB; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Weissfeld A; Microbiology Specialists Inc., Houston, Texas., Trevino E; Microbiology Specialists Inc., Houston, Texas., DeCrescenzo G; BioMed Valley Discoveries Inc., Kansas City, Missouri., Collins A; BioMed Valley Discoveries Inc., Kansas City, Missouri., Miller M; BioMed Valley Discoveries Inc., Kansas City, Missouri., Salstrom JL; PAREXEL International, Waltham, Massachusetts., Korn RL; Imaging Endpoints, Scottsdale, Arizona., Zhang L; BioMed Valley Discoveries Inc., Kansas City, Missouri., Saha S; BioMed Valley Discoveries Inc., Kansas City, Missouri.; Atlas Venture, Boston, Massachusetts., Leontovich AA; Biomedical Informatics, Mayo Clinic, Rochester, Minnesota., Tung D; BioMed Valley Discoveries Inc., Kansas City, Missouri., Kreider B; BioMed Valley Discoveries Inc., Kansas City, Missouri., Varterasian M; BioMed Valley Discoveries Inc., Kansas City, Missouri., Khazaie K; Department of Immunology, Mayo Clinic, Rochester, Minnesota. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org., Gounder MM; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 96-106. Date of Electronic Publication: 2020 Oct 12.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33046513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Janku+F%22">Janku F</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Zhang+HH%22">Zhang HH</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Pezeshki+A%22">Pezeshki A</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Goel+S%22">Goel S</searchLink>; Montefiore/Albert Einstein Cancer Center, Bronx, New York.<br /><searchLink fieldCode="AU" term="%22Murthy+R%22">Murthy R</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Wang-Gillam+A%22">Wang-Gillam A</searchLink>; Washington University in St. Louis, St. Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Shepard+DR%22">Shepard DR</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Helgason+T%22">Helgason T</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Masters+T%22">Masters T</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hong+DS%22">Hong DS</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Piha-Paul+SA%22">Piha-Paul SA</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Karp+DD%22">Karp DD</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Klang+M%22">Klang M</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Huang+SY%22">Huang SY</searchLink>; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Sakamuri+D%22">Sakamuri D</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Raina+A%22">Raina A</searchLink>; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Torrisi+J%22">Torrisi J</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Solomon+SB%22">Solomon SB</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Weissfeld+A%22">Weissfeld A</searchLink>; Microbiology Specialists Inc., Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Trevino+E%22">Trevino E</searchLink>; Microbiology Specialists Inc., Houston, Texas.<br /><searchLink fieldCode="AU" term="%22DeCrescenzo+G%22">DeCrescenzo G</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Collins+A%22">Collins A</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Miller+M%22">Miller M</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Salstrom+JL%22">Salstrom JL</searchLink>; PAREXEL International, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Korn+RL%22">Korn RL</searchLink>; Imaging Endpoints, Scottsdale, Arizona.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Saha+S%22">Saha S</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.; Atlas Venture, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Leontovich+AA%22">Leontovich AA</searchLink>; Biomedical Informatics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Tung+D%22">Tung D</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Kreider+B%22">Kreider B</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Varterasian+M%22">Varterasian M</searchLink>; BioMed Valley Discoveries Inc., Kansas City, Missouri.<br /><searchLink fieldCode="AU" term="%22Khazaie+K%22">Khazaie K</searchLink>; Department of Immunology, Mayo Clinic, Rochester, Minnesota. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Gounder+MM%22">Gounder MM</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York. fjanku@mdanderson.org khazaie@mayo.edu gounderm@mskcc.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 96-106. <i>Date of Electronic Publication: </i>2020 Oct 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33046513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-20-2065
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 96
    Titles:
      – TitleFull: Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janku F
      – PersonEntity:
          Name:
            NameFull: Zhang HH
      – PersonEntity:
          Name:
            NameFull: Pezeshki A
      – PersonEntity:
          Name:
            NameFull: Goel S
      – PersonEntity:
          Name:
            NameFull: Murthy R
      – PersonEntity:
          Name:
            NameFull: Wang-Gillam A
      – PersonEntity:
          Name:
            NameFull: Shepard DR
      – PersonEntity:
          Name:
            NameFull: Helgason T
      – PersonEntity:
          Name:
            NameFull: Masters T
      – PersonEntity:
          Name:
            NameFull: Hong DS
      – PersonEntity:
          Name:
            NameFull: Piha-Paul SA
      – PersonEntity:
          Name:
            NameFull: Karp DD
      – PersonEntity:
          Name:
            NameFull: Klang M
      – PersonEntity:
          Name:
            NameFull: Huang SY
      – PersonEntity:
          Name:
            NameFull: Sakamuri D
      – PersonEntity:
          Name:
            NameFull: Raina A
      – PersonEntity:
          Name:
            NameFull: Torrisi J
      – PersonEntity:
          Name:
            NameFull: Solomon SB
      – PersonEntity:
          Name:
            NameFull: Weissfeld A
      – PersonEntity:
          Name:
            NameFull: Trevino E
      – PersonEntity:
          Name:
            NameFull: DeCrescenzo G
      – PersonEntity:
          Name:
            NameFull: Collins A
      – PersonEntity:
          Name:
            NameFull: Miller M
      – PersonEntity:
          Name:
            NameFull: Salstrom JL
      – PersonEntity:
          Name:
            NameFull: Korn RL
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Saha S
      – PersonEntity:
          Name:
            NameFull: Leontovich AA
      – PersonEntity:
          Name:
            NameFull: Tung D
      – PersonEntity:
          Name:
            NameFull: Kreider B
      – PersonEntity:
          Name:
            NameFull: Varterasian M
      – PersonEntity:
          Name:
            NameFull: Khazaie K
      – PersonEntity:
          Name:
            NameFull: Gounder MM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2021 Jan 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1